Related Experiment Videos
Experimental aspects of T cell vaccination
Clinical and Experimental Rheumatology
|March 1, 1993
Summary
T cell vaccination (TCV) uses attenuated T cells to protect against autoimmune diseases in animal models. This therapy involves specific T cell responses, but identifying autoantigens remains a challenge for human application.
Area of Science:
- Immunology
- Autoimmune Diseases
- Experimental Medicine
Background:
- T cells play a crucial role in the development and progression of experimental autoimmune diseases.
- In vitro expanded T cell lines and clones can be pathogenic in animal models.
Purpose of the Study:
- To investigate the therapeutic potential of T cell vaccination (TCV) in experimental autoimmune diseases.
- To explore different methods of TCV and understand the underlying immune mechanisms.
Main Methods:
- Development of attenuated T cell lines (using irradiation or mitomycin C) and modified cells for vaccination.
- Administration of sub-pathogenic doses of unmodified T cells.
- Analysis of immune responses, including CD4 and CD8 T cell involvement, in vaccinated animals.
Main Results:
- Attenuated pathogenic T cells, when used for vaccination, conferred protection against disease induction.
- The protective effect of TCV was mediated by T cells.
- Vaccinated animals exhibited CD4 T cells responding to the vaccine and CD8 T cells suppressing autoantigen response.
Conclusions:
- T cell vaccination is a viable therapeutic strategy for experimental autoimmune diseases.
- The mechanism of TCV involves a complex interplay of CD4 and CD8 T cells.
- A significant barrier to clinical translation in human autoimmune diseases is the unknown identity of causative autoantigens.